Skip to main content
    P

    Protalix Biotherapeutics Inc (PLX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $2.90
    -0.13 (-4.46%)

    Market Cap: $255.49M

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Protalix Biotherapeutics Inc (PLX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Protalix Biotherapeutics (PLX) has a latest price of $2.90 on Nov 17, 2026, 9.2% below its 52-week high of $3.19. Its price rose 55.6% over the past 12 months. The month-end price fell 44.9% over the 10 years through Oct 2026, a compound annual decline of 5.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $13.60 in Mar 2017 and its lowest $0.83 in Dec 2021, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PLX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PLX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 23.2%, and over 6 months it rose 52.4%. The month-end price rose 55.1% over the 3 years through Oct 2026, a compound annual rate of 15.8%.

    PeriodChange
    1 month+13.1%
    3 months+23.2%
    6 months+52.4%
    12 months+55.6%
    12 months, with dividends+55.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+55.1%+15.8%
    5 years+129.2%+18.0%
    10 years-44.9%-5.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price rose 64.7%, and its weakest was 2021, when it fell 77.1%.

    YearCloseChange
    2026 through Oct 2026$2.59+43.9%
    2025$1.80-4.3%
    2024$1.88+5.6%
    2023$1.78+29.9%
    2022$1.37+64.7%
    2021$0.83-77.1%
    2020$3.63+10.7%
    2019$3.28+5.5%
    2018$3.11-53.0%
    2017$6.61+48.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.1% above its 50-day average of $2.70 and 18.0% above its 200-day average of $2.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.90
    52-week high$3.19-9.2%
    52-week low$1.65+75.5%
    50-day average$2.70+7.1%
    200-day average$2.45+18.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 56.0%.

    MeasureValue
    1-year beta1.06
    Largest fall, 1 year-39.7%
    Largest fall, 3 years-56.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PLX

    What is PLX's 1-year price change?

    Protalix Biotherapeutics's price rose 55.6% over the past 12 months. With dividends included, the 12-month total return was 55.6%.

    What is PLX's 5-year price change?

    Protalix Biotherapeutics's month-end price rose 129.2% over the 5 years through Oct 2026, a compound annual rate of 18.0%. These figures leave out dividends.

    What is PLX's 52-week high and low?

    Protalix Biotherapeutics's 52-week high is $3.19 and its 52-week low is $1.65. Its latest price of $2.90 on Nov 17, 2026 is 9.2% below the high.

    What is PLX's beta?

    Protalix Biotherapeutics's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 39.7%.

    Is the PLX chart free?

    Yes. Advanced Charting for PLX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.